What smart money is saying about Gilead Sciences, Inc.
GILD
No fund has written a full thesis on Gilead Sciences, Inc. in our archive, but 1 fund letter reports a position in it — most recently Baron Health Care Fund in June 2026.
1
Reported positions
0
Bought
0
Sold
1
Letter
Position history
Every position in Gilead Sciences, Inc. on record in the archive was reported in Q2 2026, across 1 fund letter, with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 1 | 0 | 0 | 0 |
Fund activity · 1 position
- June 2026
“Biotechnology company Gilead Sciences, Inc. is best known for developing and commercializing therapies that treat and prevent HIV.”
Read the letterGilead Sciences, Inc.
Read the letters behind these Gilead Sciences, Inc. positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger